SCHEMBL2413848

SCHEMBL2413848

CNc1nc(N2CCCC2CO)ccc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 2/20 0.42
PDK2 Q15119 2/20 0.41
PDK4 Q16654 1/20 0.41
ADORA2A P29274 3/20 0.39
ADORA1 P30542 3/20 0.39
MAP2K7 O14733 1/20 0.39
ADORA3 P0DMS8 2/20 0.39
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
ADK P55263 1/20 0.38
CDK1 P06493 3/20 0.38
KLKB1 P03952 1/20 0.38
KLK1 P06870 1/20 0.38
CCNE1 P24864 3/20 0.37
CDK2 P24941 3/20 0.37
ACVR1 Q04771 1/20 0.37
FPR2 P25090 1/20 0.37
SCN9A Q15858 1/20 0.37
CCNE2 O96020 1/20 0.37
CDK4 P11802 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2415018 0.88 CHUK (0.43) CHUKPDK2PDK4ADORA2AADORA1
SCHEMBL2415698 0.85 CHUK (0.40) CHUKPDK2PDK4ADORA2AADORA1
SCHEMBL2414294 0.84 CHUK (0.40) CHUKPDK2PDK4ADORA2AADORA1
SCHEMBL2415235 0.82 ADK (0.43) CHUKADORA2AADORA1ADORA3MKNK1
SCHEMBL2412675 0.81 CHUK (0.47) CHUKPDK2PDK4ADORA2AADORA1
SCHEMBL2413123 0.81 ADORA2A (0.44) CHUKADORA2AADORA1MKNK1MKNK2
SCHEMBL2413665 0.80 CHUK (0.39) CHUKPDK2PDK4ADORA2AADORA1
SCHEMBL2415080 0.80 ADORA2A (0.41) CHUKADORA2AADORA1ADORA3MKNK1
SCHEMBL2413974 0.79 CCNT1 (0.33) CDK2PDE10A
SCHEMBL2416453 0.79 HSD11B1 (0.43) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP claimed
CN-1250192-C 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2006-04-12 CN claimed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US claimed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US claimed
CN-1425365-A 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2003-06-25 CN claimed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP claimed
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP disclosed
CN-1250192-C 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2006-04-12 CN disclosed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US disclosed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US disclosed
CN-1425365-A 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2003-06-25 CN disclosed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres KRT18, DPYD, DSP CHUK 4002/4885PDK2 316/4885PDK4 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.